Understanding the Equity Financing Cycle for Startups - BusinessTown

Your business starts here.

Start-a-Business 101: Learn how to start your own business.

Understanding the Equity Financing Cycle for Startups

 Understanding the Business Lifecycle From choosing and creating your business entity, to receiving financing and liquidity, this video walks you through the entire business lifecycle.


Disclaimer: The contents of this video presentation are intended to convey general information only and are not intended to constitute legal services or the provision of legal services. This video should not be used as a substitute for obtaining legal advice from an attorney licensed or authorized to practice law in your jurisdiction. This video presentation does not constitute an offer to represent you and nothing on this website is intended to create an attorney-client relationship. The information presented in this video presentation may not reflect the most current legal developments. No action should be taken in reliance on the information contained in this video presentation and we disclaim all liability in respect to actions taken or not taken based on any or all of the contents of this site to the fullest extent permitted by law. You should contact an attorney for advice with respect to particular legal issues or problems.

About Daniel Follansbee

Daniel is partner in Mintz Levin’s Corporate & Securities Practice, focusing on the Life Sciences Sector.

He has 20 years of experience counseling both public and private clients in the biotechnology, pharmaceutical, medical device and medical technology industries. Daniel is a versatile attorney with expertise in structuring and negotiating a wide variety of corporate transactions. His clients rely on his extensive legal experience and finance expertise to advise them in all aspects of their business and legal affairs. His clients range in size from newly formed start-up ventures and venture-backed companies to substantial public companies.

Daniel serves as outside general counsel to leading life science companies, advising and counseling management and directors day-to-day, as these companies raise capital, license intellectual property, acquire technology and assets, collaborate with other companies and institutions, and realize value through negotiated M&A exits. Daniel also routinely advises boards of directors on corporate governance matters.